AF
HEPA

Allworth Financial’s Hepion Pharmaceuticals HEPA Stock Holding History

Allworth Financial’s Portfolio HEPA Stock Details HEPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$1 – 4628
2025
Q1 		$1 Buy
+1
New +$10 ﹤0.01% 4053
2024
Q4 		– Hold
0
– – – 3934
2024
Q3 		– Hold
0
– – – 3742
2024
Q2 		– Hold
0
– – – 3681
2024
Q1 		– Hold
0
– – – 3584
2023
Q4 		– Hold
0
– – – 3432
2023
Q3 		– Hold
0
– – – 3414
2023
Q2 		– Hold
0
– – – 3223
2023
Q1 		– Hold
0
– – – 3178

Other funds holding HEPA

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Allworth Financial's HEPA Position: Q2 2025 in Review

Allworth Financial sold out of Hepion Pharmaceuticals (HEPA) in Q2 2025, closing a stake of 1 share — an estimated $1 sold.

Allworth Financial first reported a position in HEPA in Q1 2025 and held it in 1 quarter. The position peaked at $1 in Q1 2025. 4 funds tracked by Wall St. Rank hold HEPA as of Q2 2025.

  • Allworth Financial reported no remaining Hepion Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Allworth Financial sold 1 Hepion Pharmaceuticals share in Q2 2025, an estimated $1.
  • Allworth Financial first reported a position in Hepion Pharmaceuticals in Q1 2025 and held it in 1 quarter.
  • Allworth Financial's Hepion Pharmaceuticals position peaked at $1 in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2025.

Based on Allworth Financial's 13F filing for Q2 2025, filed 7 Aug 2025.